| Sep 16 |
Why Bausch + Lomb Rallied Today
|
| Sep 16 |
Contact Lens Supplier Bausch + Lomb Eyes Sale Amid Separation Challenges As Parent Bausch Health Faces Debt Issues
|
| Sep 16 |
Bausch + Lomb Stock Jumps Amid Reports Of A Sale
|
| Sep 16 |
Top Midday Stories: New iPhone Sees Sluggish Demand; Boeing to Freeze Hiring, Curb Expenses; Intel Wins Defense Contract; Government Deadline to Review US Steel-Nippon Deal Nears
|
| Sep 16 |
Bausch + Lomb Soars on Report That It’s Exploring a Sale
|
| Sep 16 |
Bausch + Lomb considers sale: FT
|
| Sep 16 |
Bausch + Lomb explores sale amid parent company's debt woes - report
|
| Sep 11 |
Health Canada Approves (Pr)CABTREO(TM) (clindamycin phosphate, adapalene and benzoyl peroxide) Triple-Combination Topical Treatment for Acne Vulgaris in Patients 12 Years of Age and Older
|
| Sep 3 |
Chou RRSP Fund's Strategic Exits and New Positions in Q2 2024: Spotlight on Bausch Health ...
|
| Sep 2 |
Bausch Health Companies Inc. (BHC): Among Billionaire Carl Icahn’s Top Stock Picks
|
